Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May 31;14(6):11742-66.
doi: 10.3390/ijms140611742.

Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases

Gu-Jiun Lin  1 , Shing-Hwa Huang, Shyi-Jou Chen, Chih-Hung Wang, Deh-Ming Chang, Huey-Kang Sytwu
Affiliations
Review

Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases

Gu-Jiun Lin et al. Int J Mol Sci. .

Abstract

Melatonin is the major secretory product of the pineal gland during the night and has multiple activities including the regulation of circadian and seasonal rhythms, and antioxidant and anti-inflammatory effects. It also possesses the ability to modulate immune responses by regulation of the T helper 1/2 balance and cytokine production. Autoimmune diseases, which result from the activation of immune cells by autoantigens released from normal tissues, affect around 5% of the population. Activation of autoantigen-specific immune cells leads to subsequent damage of target tissues by these activated cells. Melatonin therapy has been investigated in several animal models of autoimmune disease, where it has a beneficial effect in a number of models excepting rheumatoid arthritis, and has been evaluated in clinical autoimmune diseases including rheumatoid arthritis and ulcerative colitis. This review summarizes and highlights the role and the modulatory effects of melatonin in several inflammatory autoimmune diseases including multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes mellitus, and inflammatory bowel disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The possible modulatory roles of melatonin in animal models and clinical trials of inflammatory autoimmune diseases.
See this image and copyright information in PMC

References

    1. Tan D.X., Manchester L.C., Hardeland R., Lopez-Burillo S., Mayo J.C., Sainz R.M., Reiter R.J. Melatonin: A hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J. Pineal Res. 2003;34:75–78. - PubMed
    1. Reiter R.J. The melatonin rhythm: Both a clock and a calendar. Experientia. 1993;49:654–664. - PubMed
    1. Malpaux B., Migaud M., Tricoire H., Chemineau P. Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. J. Biol. Rhythms. 2001;16:336–347. - PubMed
    1. Maldonado M.D., Murillo-Cabezas F., Terron M.P., Flores L.J., Tan D.X., Manchester L.C., Reiter R.J. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J. Pineal Res. 2007;42:1–11. - PubMed
    1. Peyrot F., Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J. Pineal Res. 2008;45:235–246. - PubMed

Publication types